Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskNeutral

GLOBUS MEDICAL, INC.

Filed: Mar 23, 2026CIK: 0001237831
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

John A. DeFord, Ph.D., resigned from Globus Medical's Board of Directors effective immediately on March 23, 2026, with no disagreements cited. This routine board transition has minimal immediate impact but may affect governance composition and strategic oversight.

Key Takeaways

Board member John A. DeFord resigned effective immediately with no stated disagreements with the company

The resignation was communicated via press release on the same date, indicating a planned and orderly transition

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 23, 2026
Item5.02
CategoryExecutive Change
CIK0001237831
Accession #gmed-20260323
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings